IBDEI0S7 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13924,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,13925,0)
 ;;=337.20^^90^853^68
 ;;^UTILITY(U,$J,358.3,13925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13925,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,13925,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,13925,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,13926,0)
 ;;=294.8^^90^853^14
 ;;^UTILITY(U,$J,358.3,13926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13926,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,13926,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,13926,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,13927,0)
 ;;=438.6^^90^853^4
 ;;^UTILITY(U,$J,358.3,13927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13927,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,13927,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,13927,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,13928,0)
 ;;=438.7^^90^853^7
 ;;^UTILITY(U,$J,358.3,13928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13928,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,13928,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,13928,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,13929,0)
 ;;=438.84^^90^853^3
 ;;^UTILITY(U,$J,358.3,13929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13929,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,13929,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,13929,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,13930,0)
 ;;=434.91^^90^853^8
 ;;^UTILITY(U,$J,358.3,13930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13930,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,13930,1,5,0)
 ;;=5^CVA, Acute Onset
 ;;^UTILITY(U,$J,358.3,13930,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,13931,0)
 ;;=333.94^^90^853^69
 ;;^UTILITY(U,$J,358.3,13931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13931,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,13931,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,13931,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,13932,0)
 ;;=345.90^^90^853^71
 ;;^UTILITY(U,$J,358.3,13932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13932,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,13932,1,5,0)
 ;;=5^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,13932,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,13933,0)
 ;;=907.0^^90^853^46
 ;;^UTILITY(U,$J,358.3,13933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13933,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,13933,1,5,0)
 ;;=5^Late Effect Intracranial Injury
 ;;^UTILITY(U,$J,358.3,13933,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,13934,0)
 ;;=339.00^^90^853^22
 ;;^UTILITY(U,$J,358.3,13934,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13934,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,13934,1,5,0)
 ;;=5^Headache,Cluster NOS
 ;;^UTILITY(U,$J,358.3,13934,2)
 ;;=^336741
 ;;^UTILITY(U,$J,358.3,13935,0)
 ;;=339.01^^90^853^21
 ;;^UTILITY(U,$J,358.3,13935,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13935,1,4,0)
 ;;=4^339.01
 ;;^UTILITY(U,$J,358.3,13935,1,5,0)
 ;;=5^Headache,Cluster Episodic
 ;;^UTILITY(U,$J,358.3,13935,2)
 ;;=^336545
 ;;^UTILITY(U,$J,358.3,13936,0)
 ;;=339.02^^90^853^20
 ;;^UTILITY(U,$J,358.3,13936,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13936,1,4,0)
 ;;=4^339.02
 ;;^UTILITY(U,$J,358.3,13936,1,5,0)
 ;;=5^Headache,Cluster Chronic
 ;;^UTILITY(U,$J,358.3,13936,2)
 ;;=^336546
 ;;^UTILITY(U,$J,358.3,13937,0)
 ;;=339.03^^90^853^44
 ;;^UTILITY(U,$J,358.3,13937,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13937,1,4,0)
 ;;=4^339.03
 ;;^UTILITY(U,$J,358.3,13937,1,5,0)
 ;;=5^Hemicrania,Paroxysmal,Episodic
